21
Views
2
CrossRef citations to date
0
Altmetric
Review

Moving to nucleic acid-based detection of genital Chlamydia trachomatis

&
Pages 257-266 | Published online: 09 Jan 2014

References

  • Pimenta J, Catchpole M, Gray M, Hopwood J, Randall S. Screening for genital chlamydial infection. BMJ 321, 629–631 (2000).
  • Kellogg JA, Seiple JWQ, Klinedinst JL, Stroll ES, Cavanaugh SH. Improved PCR detection of Chlamydia trachomatis by using an altered method of specimen transport and high-quality endocervical specimens.' Chn. Microbial 33,2765–2767 (1995).
  • Loeffelholz MJ, Jirsa SJ, Teske RK, Woods JN. Effect of endocervical specimen adequacy on ligase chain reaction detection of Chlamydia trachomatis. j Chn. Microbial 39,3838–3841(2001).
  • Howard C, Friedman DL, Leete JK, Christensen ML. Correlation of the percent of positive Chlamydia trachomatis direct fluorescent antibody detection tests with the adequacy of specimen collection. Diagn Microbial Infect. Dis. 14, 233–237 (1991).
  • Taylor-Robinson D, Thomas BJ. Laboratory techniques for the diagnosis of chlamydial infections. Genitourinary Med. 67,256–266 (1991).
  • Thomas BJ, Macleod EJ, Taylor-Robinson D. Evaluation of sensitivity of 10 diagnostic assays for Chlamydia trachomatis by use of a simple laboratory procedure." Chn. Pathol 46, 912–914 (1993).
  • Black CM. Laboratory diagnosis of C. trachomatis infection. Chn. Microbial Rev. 10,160–184 (1997).
  • ••Excellent review of laboratory diagnosticmethods for Chlamydia.
  • Chemesky M, Jang D, Copes D et al. Comparison of a polymer conjugate-enhanced enzyme immunoassay to ligase chain reaction for diagnosis of Chlamydia trachomatis in endocervical swabs. J. Chn. Microbial 39,2306–2307 (2001).
  • Paul I, Leese J, Caul E et al. Sensitive detection of Chlamydia trachomatis in cervical/urethral and vulvovaginal swab specimens from women using the DAKO PCE enzyme linked immunosorbent assay. Int. J. STD AIDS 12\(Suppl. 2), 118 (2001).
  • Sellors JW, Mohoney JB, Pickard L, Jang D, Groves D, Luinstra KE. Screening urine with a leukocyte esterase strip and subsequent chlamydial testing of asymptomatic men attending primary care practitioners. Sex. Trans. Dis. 20, 152–157 (1993). iiHopwood J, Mallinson H, Gleave T. Evaluation of near patient testing for Chlamydia trachomatis in a pregnancy termination service." Fain. Plan. Reprod Health. 27,127-130 (2001).
  • Schubiner HH, LeBar WD, Joseph S, Taylor C, Jemal C. Evaluation of two rapid tests for the diagnosis of Chlamydia trachomatis genital infection. Eu. j Chn. Micro. Inf Dis. 11,553-556(1992). Erratum 11,872 (1992).
  • Hadgu A. Discrepant analysis, A biased and an unscientific method for estimating test sensitivity and specificity. J. Clin. Epidemiol 52,1231–1237 (1999).
  • Wolcott MJ. Advances in nucleic acid- based detection methods. Clin. Microbial Rev. 5, 370–386 (1992).
  • ••Excellent review of nucleic acid-baseddetection methods
  • Jungkind D. Evaluation of an automated COBAS AMPLICOR PCR System for Detection of Chlanzydia trachomatisl 1Veisseria gonorrhoeae and the Impact on laboratory management. Proc. 3nd Meet. Eur Soc. Chlamydia Res. Vienna 272–273 (1996).
  • Hay PE, Thomas BJ, Homer PJ et al. Chlamydia trachomatis in women: the more you look, the more you find. Genitourin. Med.. 70, 97–100 (1994).
  • Darwin LH, Cullen AP, Arthur PM et al. Comparison of Digene Hybrid Capture 2 and conventional culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J. Clin. Microbial 40,641–644 (2002).
  • Van Doornum GJJ, Schouls LM, Pijl A, Cairo I, Buimer M, Bruisten S. Comparison between the LCx probe system and the COBAS AMPLICOR system for detection of Chlamydia trachomatis and 1Veisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, the Netherlands.' Clin. Microbial 39, 829–835 (2001).
  • •A head-to-head comparison of LCR and PCR using various specimen types.
  • Spears PA, Linn CP, Woodard DL, Walker GT. Simultaneous strand displacement amplification and fluorescence polarization detection of Chlamydia trachomatis DNA. Anal. Biochem. 247, 130–137 (1997).
  • Chan EL, Brandt K, Olienus K, Antonishyn N, Horsman GB. Performance characteristics of the Becton Dickinson ProbeTec system for direct detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male and female urine specimens in comparison with the Roche Cobas System. Arch. Pathol. Lab. Med. 124, 1649–1652 (2000).
  • Van Der Pol B, Ferrero DV, Buck—Barrington L et al. Mulitcenter evaluation of the BDProbeTec ET system for detection of Chlamydia trachomatis and 1Veisseria gonorrhoeae in urine specimens, female endocervical swabs and male urethral swabs." Clin. Microbial 39, 1008–1016 (2001).
  • Little MC, Andrews J, Moore R et al. Strand displacement amplification and homogeneous real-time detection incorporated in a second-generation DNA probe system, BDProbeTecET. Clin. Chem. 45, 777–784 (1999).
  • Van Dyck E, Ieven M, Pattyn S, Van Damme L, Logo M. Detection of Chlamydia trachomatis and 1Veisseria gonorrhoeae by enzyme immunoassay, culture and three nucleic acid amplification tests." Clin. Microbial 39, 1751–1756 (2001).
  • •A head to head comparison of HA, PCR, LCR and SDA.
  • McCartney RA, Walker J, Scoular A. Detection of Chlamydia trachomatis in genitourinary medicine clinic attendees: comparison of strand displacement amplification and ligase chain reaction. Br. Biomed Sc. 58, 235–238 (2001).
  • Check W Nucleic acid-based tests move slowly into clinical labs. ASM News 67, 560–565 (2001).
  • •An interesting article describing personal experience of moving from conventional assay to molecular diagnostic methods.
  • Pasternack R, Vuorinen P, Miettinen A. Evaluation of the Gen-Probe Chlamydia trachomatis Transcription-mediated amplification assay with urine specimens from women." Clin. Microbial 35, 676–678 (1997).
  • Crotchfelt KA, Pare B, Gaydos C, Quinn TC. Detection of Chlamydia trachomatis by the Gen-Probe Amplified Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J. Clin. Microbial 36, 391–394 (1998).
  • Stary A, Schuh E, Kerschbaumer M, Götz B, Lee H. Performance of transcription-mediated amplification and ligase chain reaction assays for detection of Chlamydial infection in urogenital samples obtained by invasive and non-invasive methods. J. Clin. Microbial. 36, 2666–2670 (1998).
  • Moller JK, Anderson B, Olesen F, Lignell T, Ostergaard L. Impact of menstrual cycle on the diagnostic performance of LCR, TMA and PCE for detection of C. trachomatis in home obtained and mailed vaginal flush and urine samples. Sex. Trans. Inf 75, 228–230 (1999).
  • Mahony J, Chong S, Jang D et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity.' Clin. Microbial 36, 3122–3126 (1998).
  • •Identification of inhibitors in different molecular diagnostic tests.
  • Shah JS, Liu J, Smith J, Popoff S et al Novel, ultrasensitive, Q-I3 replicase-amplified hybridisation assay for detection of Chlamydia trachomatis. Clin. Microbial 32, 2 718–2724 (1994).
  • Stefano JE, Genovese L, An Q et al. Rapid and sensitive detection of Chlamydia trachomatis using a ligatable binary RNA probe and Q-13 replicase. Mot Cell. Probes 11, 407–426 (1997).
  • An Q, Liu J, O'Brien W et at Comparison of characteristics of Q-I3 replicase-amplified assay with competitive PCR assay for Chlamydia trachomatis. j Clin. Microbial 33,5 58–63 (1995).
  • Song X, Coombes BK, Mahony JB. Quantitation of Chlamydia trachomatis 16S rRNA using NASBA amplification and a bioluminescent microtiter plate assay. Comb. Chem. High Throughput Screen. 4, 303–313 (2000).
  • Mahony JB, Song X, Chong S, Faught M, Salonga T, Kapala J. Evaluation of the NucliSens Basic Kit for detection of Chlamydia trachomatis and 1Veisseria gonorrhoeae in genital tract specimens using nucleic acid sequence-based amplification of 16S rRNA.1 Clin. Microbial 39, 1429–1435 (2001).
  • Morre SA, Sillekens PT, Jacobs MV et al. Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification. Mot Pathol 51, 149–154 (1998).
  • Zhang DY, Zhang W Li X, Konomi Y. Detection of rare DNA targets by isothermal ramification amplification. Gene 274, 209–216 (2001).
  • Zhang W, Cohenford M, Lentrichia B et al. Detection of Chlamyia trachomatis by isothermal ramification amplification method: a feasibility study. J. Clin. Microbial 40, 128–132 (2002).
  • Peterson EM, Darrow V, Blanding J, Aartnaes S, De La Maza LM. Reproducibility problems with the AMPLICOR PCR Chlamydia trachomatis test." Clin. Microbial 35, 957–959 (1997).
  • •Describes the problem of reproducibility with Amplicor.
  • Gronowski AM, Copper S, Baorto D, Murray PR Reproducibility problems with the Abbott Laboratories LCx assay for Chlamydia trachomatis and 1Veisseria gonorrhoeae. I Clin. Microbial 38, 2416–2418 (2000).
  • •Describes the problem of reproducibility with LCx.
  • Mahony JB, Luinstra KE, Jang D, Sellors J, Chemesky MA. Chlamydia trachomatis confirmatory testing of PCR-positive genitourinary specimens using a second set of plasmid primers. Mal Cell Probes 6, 381–388 (1992).
  • Scottish Intercollegiate Guidelines Network Management of Genital Chlamydia trachomatis Infection. SIGN Publication Number 42. March 2000 (available on www.sign.ac.uk).
  • ••A comprehensive guideline withstatements of evidence and grades of recommendation.
  • Scoular A, McCartney R, Kirin S, Carr S, Walker A. The 'real-world' impact of improved diagnostic techniques for Chlamydia trachomatis infection in Glasgow. Commun. Dis. Public Health 4, 200–204 (2001).
  • •Economic study of Chlamydia screening using LCR.
  • Lisby G, Scheibel J, Abrahamsson LO, Christensen ES, Paloheimo S. Detection of Chlamydia trachomatis in individual and pooled endocervical and urethral scrapes by a commercially available polymerase chain reaction. APMIS 102, 797–800 (1994).
  • •Describes the use of specimen pooling.
  • Catchpole M, Gray M, Hopwood J, Mallinson H et al Chlamydia trachomatis Screening Pilot: project initiation document. 20889 1P 300, March 2000, Department of Health, UK (available on www.doh.gov.uldnsc/pdfs/ pilotprotocoldec99.pde.
  • Kaceria KA, Quinn SB, Howell MR Madico GE, Quinn TC, Gaydos CA. Pooling of urine samples for ligase chain reaction screening for genital chlamydia trachomatis in asymptomatic women." Clin. Microbial 36,481–485 (1998).
  • •Describes the use of specimen pooling and regulatory acceptance.
  • Stary A, Ching S-F, Teodorowicz L, Lee H. Comparison of Ligase Chain reaction and Culture for detection of 1Veisseria gonorrhoeae in Genital and Extragenital Specimens. J Clin Microbial. 35,239-242 (1997).
  • Hammerschlag MR Use of nucleic acid amplification tests in investigating child sexual abuse. Sex. Trans. Inf 77, 153–157 (2001).
  • Mabey D, Peeling RW, Perkins MD. Rapid and simple point of care diagnostics for STIs. Sex. Trans. Inf 77, 397–401 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.